Pharma News - Chemdiv

FDA Approves Eprontia (topiramate) Oral Solution for Epilepsy and Preventive Treatment of Migraine

WOBURN, MA – Azurity Pharmaceuticals, Inc. a private specialty pharmaceutical company focused on developing innovative products to meet the unique needs of patients with underserved conditions, ...

Paxlovid FDA Approval Status

Paxlovid (PF-07321332) is an investigational SARS-CoV-2 protease inhibitor antiviral in development for the treatment of non-hospitalized high-risk adults with COVID-19 to prevent severe illness wh...

WHO authorisation for Covaxin

After months long safety scrutiny, the World Health Organization has included India’s indegenous Covid-19 vaccine – Covaxin in its authorised emergency use list. ...

Opiant Receives FDA Fast Track Designation for OPNT003, Nasal Nalmefene, for Treatment of Opioid Overdose

Opiant Pharmaceuticals, Inc., a company advancing medicines to better treat addictions and drug overdose, announced that the U.S. Food and Drug Administration has granted fast track designation for OP...

Pfizer's COVID-19 pill treatment reduces risk of being hospitalized or dying by 89%, company says

A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results released Friday...

Merck sees up to $7 billion in sales of COVID-19 drug through end of 2022

Merck & Co Inc (MRK.N) on Thursday said its experimental COVID-19 drug could bring in between $5 billion and $7 billion in sales through the end of next year, assuming it gains U.S. authorizati...

DeepMind’s protein-folding AI has solved a 50-year-old grand challenge of biology

AlphaFold can predict the shape of proteins to within the width of an atom. The breakthrough will help scientists design drugs and understand disease. ...

The search for people who never get COVID

An international team of researchers wants to find people who are genetically resistant to SARS-CoV-2, in the hope of developing new drugs and treatments.

FDA Approves Genentech’s Susvimo for Wet AMD

Genentech’s Susvimo (ranibizumab injection) is approved for intravitreal use via ocular implant for the treatment of neovascular age-related macular degeneration. ...

AZ to transfer certain drug rights to Covis Pharma for $270m

AstraZeneca has announced it will transfer global rights to Eklira (aclidinium bromide) and Duaklir (aclidinium bromide/formoterol) to Covis Pharma Group in a $270m deal. ...

FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases

The U.S. Food and Drug Administration, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of gene therapies f...

Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic γδT Cell Therapies Addressing Solid Tumors

Takeda Pharmaceutical Company Limited announced the exercise of its option to acquire GammaDelta Therapeutics Limited, a company focused on exploiting the unique properties of gamma delta (γδ) T ce...